Lv23
160 积分 2025-10-15 加入
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
1天前
已完结
Generating Multispecific Antibodies Through Column‐Based Redox Reactions: Part I
8天前
已完结
Application of lyophilization in pharmaceutical injectable formulations: An industry and regulatory perspective
1个月前
已完结
Antibody–Drug Conjugates: An Overview of the CMC and Characterization Process
1个月前
已完结
Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes
1个月前
已完结
皖公网安备34019202002308
